Drexel Morgan & Co.
- SEC CIK
- 0001508512
- Latest filing
- Aug 13, 2026
CVS holding history
CVS Health Corp in every 13F filed by Drexel Morgan & Co., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CVS overviewAll 13F holders of CVSFull Q2 2026 holdings
- Shares (Q1 2025)
- 0
- Sold out in Q1 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 16
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2025 | 0 | $0 | 0.0% | −600,165−100.0% | Sold out | Holders |
| Q4 2024 | 600,165 | $26.9M | 5.6% | +400,000+199.8% | Added | Holders |
| Q3 2024 | 200,165 | $12.6M | 2.3% | 00.0% | Unchanged | Holders |
| Q2 2024 | 200,165 | $11.8M | 2.5% | +99,900+99.6% | Added | Holders |
| Q1 2024 | 100,265 | $8.00M | 1.6% | +165+0.2% | Added | Holders |
| Q4 2023 | 100,100 | $7.90M | 1.8% | +100+0.1% | Added | Holders |
| Q3 2023 | 100,000 | $6.98M | 1.9% | 00.0% | Unchanged | Holders |
| Q2 2023 | 100,000 | $6.91M | 1.8% | 00.0% | Unchanged | Holders |
| Q1 2023 | 100,000 | $7.43M | 1.9% | 00.0% | Unchanged | Holders |
| Q4 2022 | 100,000 | $9.32M | 1.9% | 00.0% | Unchanged | Holders |
| Q3 2022 | 100,000 | $9.54M | 2.3% | 00.0% | Unchanged | Holders |
| Q2 2022 | 100,000 | $9.27M | 2.5% | 00.0% | Unchanged | Holders |
| Q1 2022 | 100,000 | $10.1M | 2.9% | 00.0% | Unchanged | Holders |
| Q4 2021 | 100,000 | $10.3M | 3.0% | 00.0% | Unchanged | Holders |
| Q3 2021 | 100,000 | $8.49M | 2.7% | 00.0% | Unchanged | Holders |
| Q2 2021 | 100,000 | $8.34M | 2.5% | −108−0.1% | Reduced | Holders |
| Q1 2021 | 100,108 | $7.53M | 1.9% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.